• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观扩散系数可作为预测脑胶质瘤患者生存情况的指标。

The apparent diffusion coefficient can serve as a predictor of survival in patients with gliomas.

机构信息

Department of Pathology, Jinhua Municipal Central Hospital, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, 321000, China.

Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.

出版信息

Radiat Oncol. 2024 Oct 29;19(1):149. doi: 10.1186/s13014-024-02535-1.

DOI:10.1186/s13014-024-02535-1
PMID:39472956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524024/
Abstract

BACKGROUND AND PURPOSE

Magnetic resonance imaging is indispensable for the preoperative diagnosis of glioma. This study aimed to investigate the role of the apparent diffusion coefficient values as predictors of survival in patients with gliomas.

METHODS AND MATERIALS

A retrospective analysis was conducted on 101 patients with gliomas who underwent surgery between 2015 and 2020. Diffusion-weighted MRI was performed before the surgery. The regions of interest were categorized into parenchymal area, non-enhancing peritumoral area, and necrotic or cystic area. All the patients were divided into three subgroups: the parenchyma group, the non-enhancing peritumoral signal abnormality group, and the necrosis or cyst group. Univariate and multivariate analyses were performed using COX regression.

RESULTS

In the parenchymal group, Ki67, P53, IDH, and the high or low ADC values were identified as independent prognosticators for disease-free survival, while Ki67, IDH, and the high or low ADC values for overall survival. In the non-enhancing peritumoral signal abnormality group, Ki67, P53, IDH, and the ADC /ADC ratio were identified as independent prognostic factors for disease-free survival, while Ki67, IDH, and the ADC /ADC ratio for overall survival. In the necrosis or cyst group, Ki67 was significantly associated with disease-free survival, while Ki67 and the ADC value of the necrotic or cystic area for overall survival.

CONCLUSIONS

The ADC values, including the ADC value in the parenchymal area, the ADC /ADC ratio, and the ADC value in the necrotic or cystic area, can serve as an efficient and potential index for predicting the survival of patients with glioma.

摘要

背景与目的

磁共振成像对于脑胶质瘤的术前诊断是不可或缺的。本研究旨在探讨表观扩散系数值作为预测脑胶质瘤患者生存的作用。

方法与材料

回顾性分析了 2015 年至 2020 年间接受手术的 101 例脑胶质瘤患者。所有患者均在术前进行了弥散加权 MRI 检查。感兴趣区分为实质区、非增强瘤周信号异常区和坏死或囊性区。所有患者分为三组:实质组、非增强瘤周信号异常组和坏死或囊性组。采用 COX 回归进行单因素和多因素分析。

结果

在实质组中,Ki67、P53、IDH 和高或低 ADC 值被确定为无病生存的独立预后因素,而 Ki67、IDH 和高或低 ADC 值则是总生存的独立预后因素。在非增强瘤周信号异常组中,Ki67、P53、IDH 和 ADC/ADC 比值被确定为无病生存的独立预后因素,而 Ki67、IDH 和 ADC/ADC 比值则是总生存的独立预后因素。在坏死或囊性组中,Ki67 与无病生存显著相关,而 Ki67 和坏死或囊性区的 ADC 值与总生存相关。

结论

ADC 值,包括实质区的 ADC 值、ADC/ADC 比值和坏死或囊性区的 ADC 值,可以作为预测脑胶质瘤患者生存的有效且有潜力的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/403913ab0f12/13014_2024_2535_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/4611368508ad/13014_2024_2535_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/09605a58636f/13014_2024_2535_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/403913ab0f12/13014_2024_2535_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/4611368508ad/13014_2024_2535_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/09605a58636f/13014_2024_2535_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11524024/403913ab0f12/13014_2024_2535_Fig3_HTML.jpg

相似文献

1
The apparent diffusion coefficient can serve as a predictor of survival in patients with gliomas.表观扩散系数可作为预测脑胶质瘤患者生存情况的指标。
Radiat Oncol. 2024 Oct 29;19(1):149. doi: 10.1186/s13014-024-02535-1.
2
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.使用标准临床磁共振成像表观扩散系数图像预测脑胶质瘤的基因型和生存:来自癌症基因组图谱的一项初步研究。
AJNR Am J Neuroradiol. 2018 Oct;39(10):1814-1820. doi: 10.3174/ajnr.A5794. Epub 2018 Sep 6.
3
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.使用定量表观扩散系数和质子磁共振波谱成像对脑胶质瘤术前肿瘤分级进行诊断检查性能的测量。
Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.
4
Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.通过表观扩散系数测量无创评估弥漫性中线胶质瘤 H3 K27M 突变状态。
Eur J Radiol. 2019 May;114:152-159. doi: 10.1016/j.ejrad.2019.03.006. Epub 2019 Mar 14.
5
Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.非钆增强型 WHO 分级 II/III 级胶质瘤的分子亚型的表观扩散系数:容积分割与二维感兴趣区分析。
Eur Radiol. 2018 Sep;28(9):3779-3788. doi: 10.1007/s00330-018-5351-0. Epub 2018 Mar 23.
6
Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.表观扩散系数在鉴别高级别胶质瘤与脑转移瘤中的诊断价值
Acta Radiol. 2018 May;59(5):599-605. doi: 10.1177/0284185117727787. Epub 2017 Aug 23.
7
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.定量表观扩散系数在脑肿瘤及相关瘤周水肿特征描述中的应用
Acta Radiol. 2009 Jul;50(6):682-9. doi: 10.1080/02841850902933123.
8
Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.弥散加权成像在世界卫生组织分级 II 级和 III 级胶质瘤基因分型中的区域和容积参数:方法比较。
AJNR Am J Neuroradiol. 2021 Mar;42(3):441-447. doi: 10.3174/ajnr.A6965. Epub 2021 Jan 7.
9
Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.使用3T高或标准b值扩散加权磁共振成像对幕上胶质瘤进行术前分级
Diagn Interv Imaging. 2017 Mar;98(3):261-268. doi: 10.1016/j.diii.2016.11.005. Epub 2016 Dec 28.
10
Diagnostic role of apparent diffusion coefficient combined with intratumoral susceptibility signals in differentiating high-grade gliomas from brain metastases.表观扩散系数联合瘤内磁敏感信号对高级别胶质瘤与脑转移瘤的鉴别诊断价值。
Neuroradiol J. 2021 Jun;34(3):169-179. doi: 10.1177/1971400920980164. Epub 2020 Dec 14.

本文引用的文献

1
Presurgical diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical perspectives from radiologists in neuro-oncology units.成人弥漫性胶质瘤的术前诊断:神经肿瘤学单位放射科医生基于 2021 年世卫组织的实用观点。
Radiologia (Engl Ed). 2024 May-Jun;66(3):260-277. doi: 10.1016/j.rxeng.2024.03.002. Epub 2024 Mar 23.
2
Expression analysis of human glioma susceptibility gene and in human glioma and its clinical significance based on bioinformatics.基于生物信息学的人类胶质瘤易感基因在人胶质瘤中的表达分析及其临床意义
Ann Transl Med. 2023 Jan 31;11(2):53. doi: 10.21037/atm-22-5646.
3
Pretreatment Apparent Diffusion Coefficient as a Predictor of Response to Transcatheter Arterial Chemoembolization Immediately Combined with Radiofrequency Ablation for Treatment of Solitary Large Hepatocellular Carcinoma.
治疗孤立性大肝细胞癌时,术前表观扩散系数作为经动脉化疗栓塞术联合射频消融术疗效预测指标的研究
Cancer Manag Res. 2020 Oct 14;12:10127-10138. doi: 10.2147/CMAR.S270470. eCollection 2020.
4
Efficiency of High and Standard Value Diffusion-Weighted Magnetic Resonance Imaging in Grading of Gliomas.高值与标准值扩散加权磁共振成像在胶质瘤分级中的效能
J Oncol. 2020 Sep 14;2020:6942406. doi: 10.1155/2020/6942406. eCollection 2020.
5
Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.环状 RNA CDR1as 破坏 p53/MDM2 复合物抑制Gliomagenesis。
Mol Cancer. 2020 Sep 7;19(1):138. doi: 10.1186/s12943-020-01253-y.
6
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.弥散磁共振成像表型预测大肿瘤负荷复发性胶质母细胞瘤中贝伐珠单抗或手术的总生存获益。
Neurosurgery. 2020 Oct 15;87(5):931-938. doi: 10.1093/neuros/nyaa135.
7
Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.复发性脑胶质瘤抗血管生成治疗早期反应的识别:酰胺质子转移加权和灌注加权 MRI 与弥散加权 MRI 的比较。
Radiology. 2020 May;295(2):397-406. doi: 10.1148/radiol.2020191376. Epub 2020 Mar 10.
8
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.表观扩散系数和肿瘤体积测量有助于对接受贝伐单抗治疗的复发性多形性胶质母细胞瘤患者的无进展生存期进行分层。
Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8.
9
The relationship between MRI quantitative parameters and the expression of hypoxia inducible factor-1 alpha in cerebral astrocytoma.脑星形细胞瘤中MRI定量参数与缺氧诱导因子-1α表达的关系
Clin Neurol Neurosurg. 2017 Feb;153:14-19. doi: 10.1016/j.clineuro.2016.11.013. Epub 2016 Nov 23.
10
Epidemiology of Brain Tumors.脑肿瘤流行病学
Neurol Clin. 2016 Nov;34(4):981-998. doi: 10.1016/j.ncl.2016.06.014.